Skip to main content
Neural Regeneration Research logoLink to Neural Regeneration Research
. 2022 Sep 16;18(4):756–759. doi: 10.4103/1673-5374.354512

Potential physiological and pathological roles for axonal ryanodine receptors

David P Stirling 1,*
PMCID: PMC9700104  PMID: 36204832

Abstract

Clinical disability following trauma or disease to the spinal cord often involves the loss of vital white matter elements including axons and glia. Although excessive Ca2+ is an established driver of axonal degeneration, therapeutically targeting externally sourced Ca2+ to date has had limited success in both basic and clinical studies. Contributing factors that may underlie this limited success include the complexity of the many potential sources of Ca2+ entry and the discovery that axons also contain substantial amounts of stored Ca2+ that if inappropriately released could contribute to axonal demise. Axonal Ca2+ storage is largely accomplished by the axoplasmic reticulum that is part of a continuous network of the endoplasmic reticulum that provides a major sink and source of intracellular Ca2+ from the tips of dendrites to axonal terminals. This “neuron-within-a-neuron” is positioned to rapidly respond to diverse external and internal stimuli by amplifying cytosolic Ca2+ levels and generating short and long distance regenerative Ca2+ waves through Ca2+ induced Ca2+ release. This review provides a glimpse into the molecular machinery that has been implicated in regulating ryanodine receptor mediated Ca2+ release in axons and how dysregulation and/or overstimulation of these internodal axonal signaling nanocomplexes may directly contribute to Ca2+-dependent axonal demise. Neuronal ryanodine receptors expressed in dendrites, soma, and axonal terminals have been implicated in synaptic transmission and synaptic plasticity, but a physiological role for internodal localized ryanodine receptors remains largely obscure. Plausible physiological roles for internodal ryanodine receptors and such an elaborate internodal binary membrane signaling network in axons will also be discussed.

Keywords: axomyelinic synapse, axon, axoplasmic reticulum, calcium, ryanodine receptor, secondary axonal degeneration, spinal cord injury, voltage-gated calcium channel, white matter injury

Background

Since the remarkable discovery that ryanodine receptor (RyR) mediated Ca2+ release from internal Ca2+ stores can contribute to central myelinated fiber conduction failure following white matter injury (Thorell et al., 2002; Ouardouz et al., 2003), much has been learned about the molecular mechanisms that regulate the release and storage of internal Ca2+ within axons and their supporting glia. Resting levels of free Ca2+ within the neuronal soma, dendrites, and axon must be tightly regulated to avoid Ca2+ mediated damage but be readily available for the intraneuronal signaling needs of the cell that often expands over great distances. This task is largely accomplished through a continuous network of endoplasmic reticulum (ER) that extends from the tips of dendrites to axonal terminals providing a major sink and source of intracellular Ca2+. This excitable and dynamic intracellular network presumably functions as a “neuron-within-a-neuron” and is positioned to rapidly respond to diverse external and internal stimuli by amplifying cytosolic Ca2+ levels and generating short and long distance regenerative Ca2+ waves (Berridge, 1998). This review provides a glimpse into the molecular machinery that has been implicated in RyR-mediated Ca2+ release in axons and how dysregulation and/or overstimulation of these internodal axonal signaling nanocomplexes may directly contribute to Ca2+-dependent axonal demise. Plausible physiological roles for such an elaborate internodal binary membrane signaling network will also be discussed.

Search Strategy and Selection Criteria

PubMed search was performed using keywords ryanodine receptor AND axon up to May 24, 2022.

Physiological Roles for Neuronal Ryanodine Receptor-Mediated Ca2+ Release

The rapid and regenerative release of Ca2+ from the ER lumen is mediated in part by RyR. There are three known isoforms (RyR1–3) and RyR1 and RyR2 are best known for their established role in excitation-contraction coupling in skeletal and cardiac muscle respectively. In skeletal muscle, RyR1 is activated by physical interactions when the voltage-gated L-type Ca2+ channel Cav1.1 undergoes conformational changes following depolarization of the sarcolemma (Woll and Van Petegem, 2022). Thus, RyR1 activation occurs without the need for an initial Ca2+ influx. In contrast, in cardiac muscle, RyR2 is activated by Ca2+ influx following activation of the voltage-gated L-type Ca2+ channel Cav1.2 (Woll and Van Petegem, 2022). RyR can then stimulate other RyR propagating the Ca2+ signal through a process termed Ca2+ induced Ca2+ release (CICR).

All three isoforms are expressed in the brain with RyR2 being the most abundant (Abu-Omar et al., 2018; Santulli et al., 2018). RyR1 has been detected in most brain regions but is highly expressed in the cerebellum within Purkinje cells, and the dentate gyrus of the hippocampus (Furuichi et al., 1994). RyR2 is also widely distributed with the highest levels of expression within the hippocampus CA1–3 regions and dentate gyrus, the granule cell layer of the cerebellum, and cerebral cortex (Sah et al., 1993; Furuichi et al., 1994). RyR3 expression often overlaps the other RyR isoforms with high expression levels within the CA1 region of the hippocampus (Sah et al., 1993; Furuichi et al., 1994). RyR is exclusively localized to the ER and axoplasmic reticulum (AR) and have been detected in dendritic shafts, spines, soma, axonal initial segment, axon, and axonal terminals (Segal and Korkotian, 2014; Abu-Omar et al., 2018).

Consistent with their differential subcellular distribution and expression within specific regions of the brain, RyR has been implicated in synaptic transmission, synaptic plasticity, learning, and memory (Abu-Omar et al., 2018; Santulli et al., 2018; Woll and Van Petegem, 2022). In support, RyR-mediated Ca2+ release plays an important role in long-term potentiation and long-term depression, two activity-dependent forms of synaptic plasticity that are commonly used to investigate the cellular basis of learning and memory formation (Baker et al., 2013; Paula-Lima et al., 2014). For example, recordings of presynaptic Ca2+ transients at the hippocampal mossy fiber-CA3 synapse revealed that CICR mediated by RyR amplified presynaptic Ca2+ levels in an activity-dependent manner which is critically important for presynaptic forms of plasticity (Shimizu et al., 2008). Interestingly, RyR2 expression was localized specifically within the mossy fiber axons rather than their terminals, whereas RyR1 was expressed postsynaptically. Thus, the differential subcellular location of the RyR isoforms provides important insight into their role in neuronal Ca2+ signaling, function, and dysfunction.

More recently, a novel mouse model of GFP-tagged RyR2 was used to more definitively determine the subcellular localization of RyR2 within the hippocampus and revealed that RyR2 was localized to the soma and dendrites of CA1 pyramidal neurons, dentate gyrus granular neurons, and mossy fiber axons, but absent from dendritic spines (Hiess et al., 2022). Utilizing a gain of function RyR2 mutant mouse model, it was demonstrated that RyR2-mediated Ca2+ release plays an important role in neuronal excitability, learning, and memory (Hiess et al., 2022). RyR has also been shown to propagate the Ca2+ signal generated in dendritic spines, dendrites, and soma to the nucleus to induce known gene expression changes required for learning and memory (Lobos et al., 2021).

In contrast to RyR2 and RyR1, RyR3 knockout mice are viable and therefore their behavior, as well as their function, can be assessed. Compared to littermate controls, RyR3 knockout mice were generally hyperactive, less social, exhibited impairments in contextual fear conditioning and passive avoidance, and had altered spatial learning. However, discrepancies with spatial and working memory as well as reversal learning performance were reported between the studies (Takeshima et al., 1996; Balschun et al., 1999; Matsuo et al., 2009). In agreement with the hippocampal associated behavioral differences, RyR3 knockout mice had altered long-term potentiation and LDP (Balschun et al., 1999; Futatsugi et al., 1999; Shimuta et al., 2001). More recently, it was shown that RyR3 activity and CICR play an essential role in neuronal excitability through modulation of activity-dependent potentiation of slow after hyperpolarising current involved in spike frequency adaptation (Tedoldi et al., 2020) adding to the complexity of RyR3 in neuronal function.

The generation of conditional neuron-specific RyR1, -2, and -3 mice will help clarify the precise physiological roles of each of the RyR isoforms in the nervous system. Collectively the data support an important physiological role for RyR in synaptic plasticity, learning, and memory. Given the importance of RyR in these aspects of neuronal function, it is not surprising that dysregulation of neuronal RyR mediated Ca2+ release through trauma or disease could contribute to neuronal hyperexcitability, neurodegeneration, cognitive impairment, and white matter injury. As a full exploration of the role of RyR in developmental disorders, aging, and neurodegenerative disease are beyond the scope of this review the interested reader is referred to additional articles on these important areas of research (Abu-Omar et al., 2018; Kushnir et al., 2018; Keil et al., 2019; Sethi et al., 2021).

Ca2+ and White Matter Injury

Central myelinated axons provide critical communication between neurons, and disruption through injury or disease contributes to serious and often permanent clinical disability. Although the precise molecular mechanisms that mediate axonal injury are incompletely understood, it is widely accepted that axonal degeneration is set in motion by an influx of extracellular Ca2+ that if unabated culminates in Ca2+-dependent enzymatic cleavage events, cytoskeletal disruption, and eventual axonal demise (Hill et al., 2016).

Mechanistically, ex vivo preparations of white matter (e.g., optic nerve, and dorsal columns) have been instrumental in our understanding of how axons are injured by a variety of insults (Stirling and Stys, 2010). Advantages of these models include the ability to maintain highly controlled environmental conditions to mimic in vivo conditions but be able to precisely manipulate the external milieu (e.g., removal of external Ca2+ from the perfusate). These models when combined with electrophysiological and optical imaging recordings of cell type specific fluorescent markers and genetically encoded Ca2+ indicators/dyes, provide a unique window into white matter function, and the dynamic response of axons and their supportive glia to injury in real time. Although ex vivo preparations closely mimic what is observed in in vivo models, limitations clearly exist including a relatively short period of observation and the exclusion of blood-derived elements.

“Outside in” and “Inside out” Sources of Ca2+

Important insights gained from using ex vivo white matter preparations have shown that removal of external Ca2+ from the perfusate is highly protective in several models of white matter injury, establishing Ca2+ entry from external sources as detrimental (Stys et al., 1990; Stirling and Stys, 2010). Subsequent pharmacological studies revealed that voltage-gated Ca2+ channels, reverse operation of the Na+-Ca2+ exchanger, and glutamate receptors accounted for the majority of Ca2+ influx (Fern et al., 2014). In addition to Ca2+ influx across the axolemma, Ca2+ can also be mobilized from intra-axonal Ca2+ stores. The major Ca2+ store in axons is the continuous network of tubular smooth ER referred to as the AR and to a lesser extent mitochondria. Indeed, total axonal Ca2+ levels approach 1 mM in axons, and free axoplasmic levels of Ca2+ are ~100 nM, suggestive that inappropriate and excessive release of Ca2+ from the AR lumen could induce significant damage alone or in combination with external sources (Stys et al., 1997).

Role of Ryanodine Receptor in White Matter Injury

Thorell et al. (2002) examined the role of intracellular sourced Ca2+ in posttraumatic axonal conduction loss following a compressive injury to the spinal cord. They observed that pretreatment with caffeine, a RyR agonist, dose dependently worsened compound action potential recovery after compressive spinal cord injury (SCI), whereas pretreatment with either RyR antagonists’ ryanodine or dantrolene improved compound action potential recovery.

Ouardouz et al. (2003) used an oxygen/glucose deprivation model and showed that the severe propagation failure of dorsal column fibers was surprisingly not recoverable in the absence of extracellular Ca2+, suggesting that intracellular sources of Ca2+, and/or Ca2+-independent processes may also play a role. In support of the former, removal of external Ca2+ from the perfusate combined with chelation of internal Ca2+ in axons conferred robust protection implicating axonal Ca2+ stores as a source of pathological Ca2+ (Ouardouz et al., 2003). Further manipulations showed that depolarization and activation of Na+ channels contributed to conduction block implicating ischemic membrane depolarization, Na+ influx, or both processes in mediating Ca2+ release from intra-axonal Ca2+ stores (Ouardouz et al., 2003). To rule out a role for Na+ influx, they substituted Li+ for Na+ in the external bath solution. Li+, a monovalent cation, permeates Na+ channels and depolarizes axons revealing that ischemic membrane depolarization, rather than Na+ influx promoted Ca2+ release in axons (Ouardouz et al., 2003). Importantly, live imaging of Ca2+ dynamics directly in axons, in the absence of external Ca2+ in the perfusate, established a mechanistic link between ischemia-induced depolarization and mobilization of luminal Ca2+ in axonal injury.

The Role of Ryanodine Receptor in Secondary Axonal Degeneration after Spinal Cord Injury

To assess the role of AR Ca2+ release in secondary axonal injury, we developed a two-photon excitation laser-induced SCI model to simultaneously follow dynamic morphological and Ca2+ changes in living myelinated dorsal column fibers acutely after injury (Stirling et al., 2014) (Figure 1). The major advantage of this model from a therapeutic viewpoint is the ability to visually differentiate in real-time primary injured axons (i.e., directly transected) from indirectly injured neighboring axons (i.e., secondary “bystander” injured axons). We found that both “primary” transected axons and “secondary” injured axons both experienced robust increases in axonal Ca2+ that propagated along the length of the axon before undergoing dieback and spheroid formation respectively (Stirling et al., 2014) (Figure 1). Importantly, the removal of external Ca2+ failed to protect axons from secondary degeneration. However, targeting of both AR Ca2+ release receptors (RyR and IP3R) was highly protective and reduced secondary “bystander” degeneration of axons (Stirling et al., 2014). Conversely, a RyR2 gain-of-function mutant (RyR2 R4496C+/+ mutant mice) as well as caffeine-induced RyR mediated Ca2+ release worsened these events (Stirling et al., 2014). We next showed that delayed inhibition of RyR alone by ryanodine or RyR knockdown was highly protective and reduced axonal dieback and secondary axonal degeneration after SCI (Orem et al., 2017). Collectively, although all three RyR isoforms have been localized to both uninjured and injured axons, these data provide evidence that RyR2 may play a detrimental role in “bystander” secondary axonal degeneration after SCI (Stirling et al., 2014; Orem et al., 2017; Pelisch et al., 2017).

Figure 1.

Figure 1

Schematic of proposed RyR-mediated axonal injury pathway.

1. Intra-axonal Ca2+ levels are kept extremely low in uninjured axons as indicated in blue. 2. SCI, indicated by the black stellate shape, results in depolarization, and subsequent Na+ and Ca2+ accumulation into axons. The initial Ca2+ increase (see Ca2+ heat map) can be mediated by axolemma localized ionotropic glutamate receptors, voltage-gated Ca2+channels, reversal of Na+-Ca2+ exchange, and through disruptions in the axolemma itself. This in turn causes the axoplasmic reticulum (AR) to release Ca2+ and CICR, indicated by the directional arrows above the Ca2+ heat map) mediated by RyR (and/or IP3R). 3. Pronounced CICR results in AR Ca2+ depletion, pathological intra-axonal Ca2+ levels and contributes to secondary axonal degeneration (a), acute Wallerian degeneration (c), delayed proximal (b), and distal (d) axonal dieback, the latter preceding Wallerian degeneration. 4. Close up of an axonal spheroid (a) reveals the proposed molecular machinery involved. The internodal axonal signaling nanocomplexes consist of axolemma localized ionotropic glutamate receptors (blue) and voltage-gated Ca2+ channels (orange), and nNOS (not shown) that drive AR Ca2+ release into the axoplasm through RyR (purple). “Cardiac like” CICR can be induced by Cav1.3 (4a) and GluA4 (4b) through depolarization and ligand binding respectfully resulting in Ca2+ entry that induces RyR2 and possibly RyR3 mediated Ca2+ release (yellow arrows indicate the direction of Ca2+ flow). (4c) GluK2 activation and depolarization can either activate RyR2/RyR3 through Ca2+ itself like GluA4 and/or cause a conformational change in Cav1.2 activating RyR1 analogous to RyR1 activation in skeletal muscle. If unabated, intra-axonal Ca2+ accumulates resulting in pathological Ca2+ levels that activate Ca2+-dependent proteases resulting in cytoskeletal breakdown and axonal demise. AR: Axoplasmic reticulum; Cav: voltage-gated calcium channel; CICR: calcium induced calcium release; GluA4: ionotropic glutamate receptor, AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) 4 (alpha 4); GluK2: ionotropic glutamate receptor, kainate 2 (beta 2); nNOS: neuronal nitric oxide synthase; RyR: ryanodine receptor; SCI: spinal cord injury.

Putative Roles of Ryanodine Receptor Following Contusive Spinal Cord Injury In Vivo

As the above ex vivo studies showed convincing evidence that RyR contributed to axonal injury, we assessed whether RyR inhibition would protect axons after contusive SCI in vivo. We first assessed the spatiotemporal expression of the three RyR isoforms after a 50 kilodyne, T9/10 contusive SCI from 1 to 7 days after SCI. We found that RyR3 mRNA was significantly increased in lumbar dorsal root ganglion (DRG) and at the lesion site at 1 and 2 days after SCI, whereas RyR2 mRNA was only increased at the lesion site at 1 day after SCI (Pelisch et al., 2017). RyR2 and RyR3 protein expression was localized to lumbar DRG neurons and their spinal projections within the lesion site acutely after SCI (Pelisch et al., 2017). In contrast, RyR1 was unaltered following SCI (Pelisch et al., 2017). These results showed acute differential expression of RyR isoforms in DRG and spinal cord after SCI and revealed that RyR3 in addition to RyR1 and RyR2, may also influence SCI outcome.

We then used two-photon excitation intravital microscopy to document the dynamic changes of dorsal column axons following a contusive SCI in vivo. We found that RyR inhibition within 15 minutes of SCI significantly reduced axonal spheroid formation and prevented secondary degeneration of axons at 24 hours after SCI (Orem et al., 2022). However, delayed inhibition of RyR had no effect on acute axonal spheroid formation but significantly increased axonal survival (Orem et al., 2022). We generated triple transgenic Avil-Cre:Ai9fl/fl:Ai95fl/fl mice that express the genetically-encoded Ca2+ indicator GCaMP6f in tdTomato positive DRG neurons that project their axons within the dorsal columns and showed that RyR inhibition reduced intra-axonal Ca2+ levels at 24 hours after SCI (Orem et al., 2022).

Currently, there is one published study that has assessed the role of RyR in SCI that included assessment of behavioral recovery. Liao et al. (2016) injected lentiviral shRNAi-RyR2 directly into the spinal cord to knock down RyR2 function prior to a moderate contusion injury in the rat. Remarkably, they reported that RyR2 knockdown significantly improved locomotor recovery (Basso, Beattie, and Bresnahan locomotor rating scale and combined behavioral scores) and reduced lesion size by almost 50% compared to controls after SCI (Liao et al., 2016). Given that the contusion was at thoracic level T9, the improved functional outcome likely involved sparing of white matter tracts. The authors then went on to show that mechanistically, the RyR2 knockdown reduced proinflammatory cytokine levels, improved spinal cord oxygen consumption rate, reduced ER stress, and oxidative stress in part through the reduction in NADPH oxidase-2 expression (Liao et al., 2016). Collectively, these studies provide strong evidence that RyR inhibition protects axons and improves functional outcomes after SCI through both direct and indirect effects.

Internodal Axonal Nanocomplexes and Ca2+ Dysregulation

To further our understanding of the molecular mechanisms that regulate RyR activation, Stys and colleagues (Ouardouz et al., 2003) revealed a physical association between L-type Ca2+ channels and RyR in white matter. Specifically, Cav1.2 with RyR1 and Cav1.3 with RyR2, and these channels were colocalized within junctions of subaxolemmal AR and axolemma. Ultrastructural studies have also shown AR-axolemmal junctions in axons that resemble the coupling junctions between the sarcoplasmic reticulum and the T-tubules in muscle cells (Metuzals et al., 1997). Thus, analogous to “excitation-contraction coupling” in skeletal muscle, Cav1.2 localized to the axolemma acts as a voltage sensor transducing axonal depolarization to open RyR1 in a Ca2+ independent manner (Ouardouz et al., 2003). In distinction, Ca2+ influx through Cav1.3 or other axolemma localized Ca2+ permeable receptors (see below) may trigger CICR through RyR2 like cardiac muscle. Thus, both Ca2+-dependent and independent pathways could potentially activate AR localized RyR that can release damaging amounts of Ca2+ under pathological conditions in white matter (Ouardouz et al., 2003; Figure 1).

Although excitotoxicity of vital glial elements including oligodendrocytes and astrocytes had previously been implicated in white matter injury (Fern et al., 2014), axons were not thought to express functional glutamate receptors. Remarkably, further work from Stys and colleagues linked axonal localized AMPA receptor activation (GluA4) with RyR-mediated release of Ca2+ from internal stores (Ouardouz et al., 2006; Figure 1). Thus, excessive glutamate release could directly activate axonal GluA4 receptors that in turn permeate Ca2+ leading to CICR through RyR, resulting in pathological Ca2+ release in axons (Ouardouz et al., 2009a).

Further mechanistic work revealed that myelinated spinal axons also expressed functional GluK2 containing kainate receptors that formed axonal signaling “nanocomplexes” along with L-type Ca2+ channels, RyR, and nitric oxide synthase (Ouardouz et al., 2009b). In this arrangement, it was proposed that the axolemma localized GluK2 induce a local depolarization and Ca2+ influx. The depolarization would activate L-type Ca2+ channels and transduce the axonal depolarization to open RyR1 and the Ca2+ influx would promote the release of nitric oxide (NO) by nNOS. NO release in turn may function to increase or modulate RyR activity as has been shown previously in skeletal muscle (Ouardouz et al., 2009b).

Importantly, this binary membrane (i.e., axolemma and AR) localized signaling nanocomplex in axons links glutamate and NO signaling to the pathological release of intra-axonal Ca2+ through RyR. As traumatic and neuroinflammatory injury processes are known to release abnormal levels of glutamate and NO, this may further perpetuate luminal Ca2+ release and directly contribute to both glial and axonal demise.

Together, the results of several independent studies support a detrimental role for RyR-mediated Ca2+ release in axonal injury, but many questions remain unanswered. Are the positive effects of RyR inhibition after injury a result of direct effects on axons or indirect effects or both? What are the roles of the individual RyR isoforms in white matter injury? Further studies will be necessary to address these questions and how best to target intra-axonal Ca2+ release to protect white matter.

Putative Physiological Roles of Ryanodine Receptor in Myelinated Axons

What are potential physiological roles of RyR in myelinated axons and the internodal nanocomplexes that lead to their activation? Although speculative, the arrangement of a continuous binary membrane signaling nanocomplex in axons and the known existence of a second longitudinal conducting pathway through the internodal periaxonal space (Cohen et al., 2020), may link conduction dynamics anywhere along the length of the axon with an elaborate regenerative intraneuronal signaling system. The latter perhaps through RyR-mediated CICR could provide real-time homeostatic feedback of activity, the local environment, and needs of the axon from any point along the axon to the distant soma. In addition, axomyelinic “synapses” may provide a highly localized link between axonal activity and the resultant metabolic needs of the axon through RyR-dependent signaling facilitating oligodendroglial-derived axonal trophic support (Micu et al., 2017) and/ or through RyR mediated Ca2+ release to axonal mitochondria to increase ATP production. Lastly, a role for RyR-dependent modulation of axomyelinic synapses could underlie activity-dependent plasticity resulting in physical changes in myelin that fine tune conduction dynamics (Cullen et al., 2021). More work in these exciting areas of research will likely unveil additional roles for axonal RyR in white matter physiology, plasticity, and injury.

Additional file: Open peer review report 1 (78.6KB, pdf) .

OPEN PEER REVIEW REPORT 1
NRR-18-756_Suppl1.pdf (78.6KB, pdf)

Footnotes

Funding: This work was supported by National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01NS092680 (to DPS).

Conflicts of interest: The author declares no conflicts of interest.

Availability of data and materials: All data generated or analyzed during this study are included in this published article and its supplementary information files.

Open peer reviewer: Pamela J. Lein, University of California Davis, USA.

P-Reviewer: Lein PJ; C-Editors: Zhao M, Liu WJ, Qiu Y; T-Editor: Jia Y

References

  • 1.Abu-Omar N, Das J, Szeto V, Feng ZP. Neuronal ryanodine receptors in development and aging. Mol Neurobiol. 2018;55:1183–1192. doi: 10.1007/s12035-016-0375-4. [DOI] [PubMed] [Google Scholar]
  • 2.Baker KD, Edwards TM, Rickard NS. The role of intracellular calcium stores in synaptic plasticity and memory consolidation. Neurosci Biobehav Rev. 2013;37:1211–1239. doi: 10.1016/j.neubiorev.2013.04.011. [DOI] [PubMed] [Google Scholar]
  • 3.Balschun D, Wolfer DP, Bertocchini F, Barone V, Conti A, Zuschratter W, Missiaen L, Lipp HP, Frey JU, Sorrentino V. Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning. EMBO J. 1999;18:5264–5273. doi: 10.1093/emboj/18.19.5264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Berridge MJ. Neuronal calcium signaling. Neuron. 1998;21:13–26. doi: 10.1016/s0896-6273(00)80510-3. [DOI] [PubMed] [Google Scholar]
  • 5.Cohen CCH, Popovic MA, Klooster J, Weil MT, Mobius W, Nave KA, Kole MHP. Saltatory conduction along myelinated axons involves a periaxonal nanocircuit. Cell. 2020;180:311–322. doi: 10.1016/j.cell.2019.11.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cullen CL, Pepper RE, Clutterbuck MT, Pitman KA, Oorschot V, Auderset L, Tang AD, Ramm G, Emery B, Rodger J, Jolivet RB, Young KM. Periaxonal and nodal plasticities modulate action potential conduction in the adult mouse brain. Cell Rep. 2021;34:108641. doi: 10.1016/j.celrep.2020.108641. [DOI] [PubMed] [Google Scholar]
  • 7.Fern RF, Matute C, Stys PK. White matter injury:ischemic and nonischemic. Glia. 2014;62:1780–1789. doi: 10.1002/glia.22722. [DOI] [PubMed] [Google Scholar]
  • 8.Furuichi T, Furutama D, Hakamata Y, Nakai J, Takeshima H, Mikoshiba K. Multiple types of ryanodine receptor/Ca2+ release channels are differentially expressed in rabbit brain. J Neurosci. 1994;14:4794–4805. doi: 10.1523/JNEUROSCI.14-08-04794.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Futatsugi A, Kato K, Ogura H, Li ST, Nagata E, Kuwajima G, Tanaka K, Itohara S, Mikoshiba K. Facilitation of NMDAR-independent LTP and spatial learning in mutant mice lacking ryanodine receptor type 3. Neuron. 1999;24:701–713. doi: 10.1016/s0896-6273(00)81123-x. [DOI] [PubMed] [Google Scholar]
  • 10.Hiess F, Yao J, Song Z, Sun B, Zhang Z, Huang J, Chen L, Institoris A, Estillore JP, Wang R, Ter Keurs H, Stys PK, Gordon GR, Zamponi GW, Ganguly A, Chen SRW. Subcellular localization of hippocampal ryanodine receptor 2 and its role in neuronal excitability and memory. Commun Biol. 2022;5:183. doi: 10.1038/s42003-022-03124-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hill CS, Coleman MP, Menon DK. Traumatic axonal injury:mechanisms and translational opportunities. Trends Neurosci. 2016;39:311–324. doi: 10.1016/j.tins.2016.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Keil KP, Sethi S, Wilson MD, Silverman JL, Pessah IN, Lein PJ. Genetic mutations in Ca(2+) signaling alter dendrite morphology and social approach in juvenile mice. Genes Brain Behav. 2019;18:e12526. doi: 10.1111/gbb.12526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kushnir A, Wajsberg B, Marks AR. Ryanodine receptor dysfunction in human disorders. Biochim Biophys Acta Mol Cell Res. 2018;1865:1687–1697. doi: 10.1016/j.bbamcr.2018.07.011. [DOI] [PubMed] [Google Scholar]
  • 14.Liao B, Zhang Y, Sun H, Ma B, Qian J. Ryanodine receptor 2 plays a critical role in spinal cord injury via induction of oxidative stress. Cell Physiol Biochem. 2016;38:1129–1137. doi: 10.1159/000443063. [DOI] [PubMed] [Google Scholar]
  • 15.Lobos P, Cordova A, Vega-Vasquez I, Ramirez OA, Adasme T, Toledo J, Cerda M, Hartel S, Paula-Lima A, Hidalgo C. RyR-mediated Ca(2+) release elicited by neuronal activity induces nuclear Ca(2+) signals CREB phosphorylation and Npas4/RyR2 expression. Proc Natl Acad Sci U S A. 2021;118:e2102265118. doi: 10.1073/pnas.2102265118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Matsuo N, Tanda K, Nakanishi K, Yamasaki N, Toyama K, Takao K, Takeshima H, Miyakawa T. Comprehensive behavioral phenotyping of ryanodine receptor type 3 (RyR3) knockout mice:decreased social contact duration in two social interaction tests. Front Behav Neurosci. 2009;3:3. doi: 10.3389/neuro.08.003.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Metuzals J, Chang D, Hammar K, Reese TS. Organization of the cortical endoplasmic reticulum in the squid giant axon. J Neurocytol. 1997;26:529–539. doi: 10.1023/a:1015482407202. [DOI] [PubMed] [Google Scholar]
  • 18.Micu I, Plemel JR, Caprariello AV, Nave KA, Stys PK. Axo-myelinic neurotransmission:a novel mode of cell signalling in the central nervous system. Nat Rev Neurosci. 2017;19:58. doi: 10.1038/nrn.2017.166. [DOI] [PubMed] [Google Scholar]
  • 19.Orem BC, Pelisch N, Williams J, Nally JM, Stirling DP. Intracellular calcium release through IP3R or RyR contributes to secondary axonal degeneration. Neurobiol Dis. 2017;106:235–243. doi: 10.1016/j.nbd.2017.07.011. [DOI] [PubMed] [Google Scholar]
  • 20.Orem BC, Rajaee A, Stirling DP. Inhibiting calcium release from ryanodine receptors protects axons after spinal cord injury. J Neurotrauma. 2022;39:311–319. doi: 10.1089/neu.2021.0350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ouardouz M, Nikolaeva MA, Coderre E, Zamponi GW, McRory JE, Trapp BD, Yin X, Wang W, Woulfe J, Stys PK. Depolarization-induced Ca2+release in ischemic spinal cord white matter involves L-type Ca2+channel activation of ryanodine receptors. Neuron. 2003;40:53–63. doi: 10.1016/j.neuron.2003.08.016. [DOI] [PubMed] [Google Scholar]
  • 22.Ouardouz M, Malek S, Coderre E, Stys PK. Complex interplay between glutamate receptors and intracellular Ca2+stores during ischaemia in rat spinal cord white matter. J Physiol. 2006;577:191–204. doi: 10.1113/jphysiol.2006.116798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ouardouz M, Coderre E, Zamponi GW, Hameed S, Yin X, Trapp BD, Stys PK. Glutamate receptors on myelinated spinal cord axons:II. AMPA and GluR5 receptors. Ann Neurol. 2009a;65:160–166. doi: 10.1002/ana.21539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ouardouz M, Coderre E, Basak A, Chen A, Zamponi GW, Hameed S, Rehak R, Yin X, Trapp BD, Stys PK. Glutamate receptors on myelinated spinal cord axons:I. GluR6 kainate receptors. Ann Neurol. 2009b;65:151–159. doi: 10.1002/ana.21533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Paula-Lima AC, Adasme T, Hidalgo C. Contribution of Ca2+release channels to hippocampal synaptic plasticity and spatial memory:potential redox modulation. Antioxid Redox Signal. 2014;21:892–914. doi: 10.1089/ars.2013.5796. [DOI] [PubMed] [Google Scholar]
  • 26.Pelisch N, Gomes C, Nally JM, Petruska JC, Stirling DP. Differential expression of ryanodine receptor isoforms after spinal cord injury. Neurosci Lett. 2017;660:51–56. doi: 10.1016/j.neulet.2017.09.018. [DOI] [PubMed] [Google Scholar]
  • 27.Sah P, Francis K, McLachlan EM, Junankar P. Distribution of ryanodine receptor-like immunoreactivity in mammalian central nervous system is consistent with its role in calcium-induced calcium release. Neuroscience. 1993;54:157–165. doi: 10.1016/0306-4522(93)90391-r. [DOI] [PubMed] [Google Scholar]
  • 28.Santulli G, Lewis D, des Georges A, Marks AR, Frank J. Ryanodine receptor structure and function in health and disease. Subcell Biochem. 2018;87:329–352. doi: 10.1007/978-981-10-7757-9_11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Segal M, Korkotian E. Endoplasmic reticulum calcium stores in dendritic spines. Front Neuroanat. 2014;8:64. doi: 10.3389/fnana.2014.00064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Sethi S, Keil Stietz KP, Valenzuela AE, Klocke CR, Silverman JL, Puschner B, Pessah IN, Lein PJ. Developmental exposure to a human-relevant polychlorinated biphenyl mixture causes behavioral phenotypes that vary by sex and genotype in juvenile mice expressing human mutations that modulate neuronal calcium. Front Neurosci. 2021;15:766826. doi: 10.3389/fnins.2021.766826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Shimizu H, Fukaya M, Yamasaki M, Watanabe M, Manabe T, Kamiya H. Use-dependent amplification of presynaptic Ca2+signaling by axonal ryanodine receptors at the hippocampal mossy fiber synapse. Proc Natl Acad Sci U S A. 2008;105:11998–12003. doi: 10.1073/pnas.0802175105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Shimuta M, Yoshikawa M, Fukaya M, Watanabe M, Takeshima H, Manabe T. Postsynaptic modulation of AMPA receptor-mediated synaptic responses and LTP by the type 3 ryanodine receptor. Mol Cell Neurosci. 2001;17:921–930. doi: 10.1006/mcne.2001.0981. [DOI] [PubMed] [Google Scholar]
  • 33.Stirling DP, Stys PK. Mechanisms of axonal injury:internodal nanocomplexes and calcium deregulation. Trends Mol Med. 2010;16:160–170. doi: 10.1016/j.molmed.2010.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Stirling DP, Cummins K, Wayne Chen SR, Stys P. Axoplasmic reticulum Ca(2+) release causes secondary degeneration of spinal axons. Ann Neurol. 2014;75:220–229. doi: 10.1002/ana.24099. [DOI] [PubMed] [Google Scholar]
  • 35.Stys PK, Ransom BR, Waxman SG, Davis PK. Role of extracellular calcium in anoxic injury of mammalian central white matter. Proc Natl Acad Sci U S A. 1990;87:4212–4216. doi: 10.1073/pnas.87.11.4212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Stys PK, Lehning E, Saubermann AJ, LoPachin RM., Jr Intracellular concentrations of major ions in rat myelinated axons and glia:calculations based on electron probe X-ray microanalyses. J Neurochem. 1997;68:1920–1928. doi: 10.1046/j.1471-4159.1997.68051920.x. [DOI] [PubMed] [Google Scholar]
  • 37.Takeshima H, Ikemoto T, Nishi M, Nishiyama N, Shimuta M, Sugitani Y, Kuno J, Saito I, Saito H, Endo M, Iino M, Noda T. Generation and characterization of mutant mice lacking ryanodine receptor type 3. J Biol Chem. 1996;271:19649–19652. doi: 10.1074/jbc.271.33.19649. [DOI] [PubMed] [Google Scholar]
  • 38.Tedoldi A, Ludwig P, Fulgenzi G, Takeshima H, Pedarzani P, Stocker M. Calcium-induced calcium release and type 3 ryanodine receptors modulate the slow afterhyperpolarising current sIAHP and its potentiation in hippocampal pyramidal neurons. PLoS One. 2020;15:e0230465. doi: 10.1371/journal.pone.0230465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Thorell WE, Leibrock LG, Agrawal SK. Role of RyRs and IP3 receptors after traumatic injury to spinal cord white matter. J Neurotrauma. 2002;19:335–342. doi: 10.1089/089771502753594909. [DOI] [PubMed] [Google Scholar]
  • 40.Woll KA, Van Petegem F. Calcium-release channels:structure and function of IP3 receptors and ryanodine receptors. Physiol Rev. 2022;102:209–268. doi: 10.1152/physrev.00033.2020. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

OPEN PEER REVIEW REPORT 1
NRR-18-756_Suppl1.pdf (78.6KB, pdf)

Articles from Neural Regeneration Research are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES